NCT05010629 2025-05-319-ING-41 Plus Carboplatin in Salivary Gland CarcinomaDana-Farber Cancer InstitutePhase 2 Active not recruiting35 enrolled
NCT04832438 2022-02-229-ING-41 Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland CarcinomaActuate Therapeutics Inc.Phase 2 Withdrawn